series-b
Stage
2014
Founded
1
Investors
About
PathoQuest provides next-generation sequencing (NGS)-based services for the biosafety assessment and quality control of biologics and vaccines, including adventitious virus detection and microbial identification.
Explore PathoQuest SAS's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.